These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiovascular risk factors, nonvalvular atrial fibrillation and retinal vein occlusion. Lisa Gracia M; Córdoba Alonso A; Hernández Hernández JL; Pérez Montes R; Napal Lecumberri JJ Rev Clin Esp (Barc); 2017 May; 217(4):188-192. PubMed ID: 27939441 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the ambulatory blood pressure monitoring in patients with retinal vein occlusion. García-Tellado Á; Solís-Sánchez P; Cerveró A; Napal-Lecumberri JJ; Lozano-Polo JL; Valero Díaz LaMadrid C Med Clin (Barc); 2023 Oct; 161(7):300-302. PubMed ID: 37423878 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012: A cross-sectional observational study. Shin YU; Cho H; Kim JM; Bae K; Kang MH; Shin JP; Nam E; Kang SW; Medicine (Baltimore); 2016 Nov; 95(44):e5185. PubMed ID: 27858854 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study. Thapa R; Bajimaya S; Paudyal G; Khanal S; Tan S; Thapa SS; van Rens G BMC Ophthalmol; 2017 Sep; 17(1):162. PubMed ID: 28865424 [TBL] [Abstract][Full Text] [Related]
10. AMBULATORY BLOOD PRESSURE PATTERNS IN PATIENTS WITH RETINAL VEIN OCCLUSION. Rao VN; Ulrich JN; Viera AJ; Parlin A; Fekrat S; Chavala SH Retina; 2016 Dec; 36(12):2304-2310. PubMed ID: 27205892 [TBL] [Abstract][Full Text] [Related]
11. Retinal vein occlusion in the general population after COVID-19 vaccination and infection. Napal B; García-Palacios JD; González-Mesones B; Napal JJ; Hernández JL Med Clin (Barc); 2023 Sep; 161(6):231-237. PubMed ID: 37263839 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Yasuda M; Kiyohara Y; Arakawa S; Hata Y; Yonemoto K; Doi Y; Iida M; Ishibashi T Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3205-9. PubMed ID: 20071683 [TBL] [Abstract][Full Text] [Related]
13. Risk factors in developing retinal vein occlusion in subject with obstructive sleep apnea. Díaz DE Terán T; González P; González M; Cerveró A; Nicolini A; Banfi P; Solidoro P; Napal JJ; Valero C Minerva Med; 2023 Dec; 114(6):825-831. PubMed ID: 35315633 [TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for retinal vein occlusion at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria. Fiebai B; Ejimadu CS; Komolafe RD Niger J Clin Pract; 2014; 17(4):462-6. PubMed ID: 24909470 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Mitchell P; Smith W; Chang A Arch Ophthalmol; 1996 Oct; 114(10):1243-7. PubMed ID: 8859084 [TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Arsène S; Delahousse B; Regina S; Le Lez ML; Pisella PJ; Gruel Y Thromb Haemost; 2005 Jul; 94(1):101-6. PubMed ID: 16113792 [TBL] [Abstract][Full Text] [Related]
20. Demographic characteristics, patterns and risk factors for retinal vein occlusion in Nepal: a hospital-based case-control study. Thapa R; Paudyal G; Bernstein PS Clin Exp Ophthalmol; 2010 Aug; 38(6):583-90. PubMed ID: 20584017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]